Literature DB >> 22707195

Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis.

Wenpeng Cui1, Bing Du, Wenhua Zhou, Ye Jia, Guangdong Sun, Jing Sun, Dongmei Zhang, Hang Yuan, Feng Xu, Xuehong Lu, Ping Luo, Lining Miao.   

Abstract

So far, case-control studies on the association between glucose transporter 1 (GLUT1) gene single nucleotide polymorphisms (SNPs) and diabetic nephropathy (DN) have generated considerable controversy. To clarify the linkage of GLUT1 SNPs on the risk of DN, a systematic review and meta-analysis was performed. A comprehensive literature search of electronic databases was conducted to obtain relative studies. Nine case-control studies were included. Significant differences were found between XbaI SNP (rs841853) and increased risk of DN in all genetic models. Subgroup analyses for Caucasians population and DN from both type 1 and type 2 diabetes also revealed positive results. For Enh2-1 SNP (rs841847), Enh2-2 SNP (rs841848) and HaeIII SNP (rs1385129), obvious linkages were demonstrated in recessive model. However, analysis for the association between HpyCH4V SNP (rs710218) and the susceptibility of DN showed no significance. Likewise, negative outcome was also found in the assessment for the influence of XbaI or Enh2-2 SNP on the pathogenesis progress of DN. The evidence currently available shows that XbaI, Enh2 and HaeIII SNPs, but not HpyCH4V SNP, in GLUT1 gene may be genetic susceptibility to DN. However, data does not support the association between either XbaI or Enh2-2 SNP and the severity of DN.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22707195     DOI: 10.1007/s11033-012-1711-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  48 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Global healthcare expenditure on diabetes for 2010 and 2030.

Authors:  Ping Zhang; Xinzhi Zhang; Jonathan Brown; Dorte Vistisen; Richard Sicree; Jonathan Shaw; Gregory Nichols
Journal:  Diabetes Res Clin Pract       Date:  2010-02-19       Impact factor: 5.602

3.  C-106T polymorphism in promoter of aldose reductase gene is a risk factor for diabetic nephropathy in type 2 diabetes patients with poor glycaemic control.

Authors:  Katarzyna Gosek; Dariusz Moczulski; Ewa Zukowska-Szczechowska; Wladyslaw Grzeszczak
Journal:  Nephron Exp Nephrol       Date:  2005-01-05

4.  Immunogold localization of high-affinity glucose transporter isoforms in normal rat kidney.

Authors:  C Heilig; C Zaloga; M Lee; X Zhao; B Riser; F Brosius; P Cortes
Journal:  Lab Invest       Date:  1995-11       Impact factor: 5.662

5.  Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes.

Authors:  W Grzeszczak; D K Moczulski; M Zychma; E Zukowska-Szczechowska; W Trautsolt; I Szydlowska
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

6.  GLUT1 gene polymorphism in non-insulin-dependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population.

Authors:  C Gutierrez; J Vendrell; R Pastor; M Broch; C Aguilar; C Llor; I Simon; C Richart
Journal:  Diabetes Res Clin Pract       Date:  1998-08       Impact factor: 5.602

7.  Minor effect of GLUT1 polymorphisms on susceptibility to diabetic nephropathy in type 1 diabetes.

Authors:  Daniel P K Ng; Luis Canani; Shin-ichi Araki; Adam Smiles; Dariusz Moczulski; James H Warram; Andrzej S Krolewski
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

8.  Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium.

Authors:  R K Studer; P A Craven; F R DeRubertis
Journal:  Diabetes       Date:  1993-01       Impact factor: 9.461

9.  Regulation of glucose uptake in mesangial cells stimulated by high glucose: role of angiotensin II and insulin.

Authors:  Carine P Arnoni; Carla Lima; Priscila C Cristovam; Edgar Maquigussa; Daniela B Vidotti; Mirian A Boim
Journal:  Exp Biol Med (Maywood)       Date:  2009-06-22

10.  XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy.

Authors:  Ioannis Stefanidis; Kyriakos Kytoudis; Afroditi A Papathanasiou; Dimitrios Zaragotas; Lambros Melistas; Georgios D Kitsios; Nikolaos Yiannakouris; Elias Zintzaras
Journal:  Dis Markers       Date:  2009       Impact factor: 3.434

View more
  7 in total

Review 1.  Diabetic kidney disease: from physiology to therapeutics.

Authors:  Carmen Mora-Fernández; Virginia Domínguez-Pimentel; Mercedes Muros de Fuentes; José L Górriz; Alberto Martínez-Castelao; Juan F Navarro-González
Journal:  J Physiol       Date:  2014-06-06       Impact factor: 5.182

2.  Losartan reverses glomerular podocytes injury induced by AngII via stabilizing the expression of GLUT1.

Authors:  S Y Yu; R Qi; H Zhao
Journal:  Mol Biol Rep       Date:  2013-09-24       Impact factor: 2.316

3.  Role of glucose metabolism related gene GLUT1 in the occurrence and prognosis of colorectal cancer.

Authors:  Wenming Feng; Ge Cui; Cheng-Wu Tang; Xiao-Lan Zhang; Chuang Dai; Yong-Qiang Xu; Hui Gong; Tao Xue; Hui-Hui Guo; Ying Bao
Journal:  Oncotarget       Date:  2017-05-23

4.  Interaction between a diabetes-related methylation site (TXNIP cg19693031) and variant (GLUT1 rs841853) on fasting blood glucose levels among non-diabetics.

Authors:  Hao-Hung Tsai; Chao-Yu Shen; Chien-Chang Ho; Shu-Yi Hsu; Disline Manli Tantoh; Oswald Ndi Nfor; Shin-Lin Chiu; Ying-Hsiang Chou; Yung-Po Liaw
Journal:  J Transl Med       Date:  2022-02-14       Impact factor: 5.531

Review 5.  Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury.

Authors:  Wenpeng Cui; Yang Bai; Ping Luo; Lining Miao; Lu Cai
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543

6.  Associations of TCF7L2 gene polymorphisms with the risk of diabetic nephropathy: A case-control study.

Authors:  Yan Zhuang; Fukun Niu; Defeng Liu; Juanjuan Sun; Xiaowei Zhang; Jian Zhang; Shuxia Guo
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

7.  The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysis.

Authors:  I Stefanidis; M Tziastoudi; E E Tsironi; E Dardiotis; S V Tachmitzi; A Fotiadou; G Pissas; K Kytoudis; M Sounidaki; G Ampatzis; P R Mertens; V Liakopoulos; T Eleftheriadis; G M Hadjigeorgiou; M Santos; E Zintzaras
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.